Loading...

Japan's drug regulator PMDA plans India office

Image

15-Oct-15 Japan's drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon. The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. [image: The Economic Times]

Read More

Vetter announces office in Japan

Image

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]

Read More

Japan university to provide telemedicine facilities in India

Image

06-Oct-15 Kyushu University in Japan has collaborated with Jawaharlal Institute of Postgraduate Medical Education & Research (Jipmer) to provide telemedicine facilities in the field of surgical gastroenterology through video conferencing. Jipmer was designated a regional resource centre for telemedicine for South India in 2013. [image: ET Healthworld]

Read More

Japan supports Mekong Delta’s medical sector

Image

05-Oct-15 Although Can Tho in Vietnam has many hospitals, equipment for diagnosis and treatment is inadequate, and the medical sector desperately needs support from countries like Japan. Narazaki Mikio, President of Japan Intl Human Resources Development Association, said they will supply medical equipment and training, adding “the more machines like MRI or CT scanners you have, the better patient treatment will be." [image: VOVworld]

Read More

Japan Pharma Manufacturers Association partners with Medidata

Image

01-Sep-15 Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutical Manufacturers Association (JPMA) to provide cloud-based technology for streamlining clinical trial costs across Japan by focusing on the consistent budgeting of trial sites. [image: BioSpectrum]

Read More